Last reviewed 2026-04-20 · How we verify

Electret electrostatic physiotherapyFilm

Peking University People's Hospital · Phase 1 active Small molecule Quality 0/100

Electret electrostatic physiotherapyFilm is a Small molecule drug developed by Peking University People's Hospital. It is currently in Phase 1 development. Also known as: polypropylene.

Likelihood of approval

9.6% vs 9.6% industry baseline

If approved by FDA: likely 2033–2036

Steps remaining: Phase 2 → Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 1 → approval rate +9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2033–2036	—
EMA	EU	2034–2037	+0.7 yr
MHRA	GB	2034–2037	+0.7 yr
Health Canada	CA	2034–2038	+0.9 yr
TGA	AU	2034–2038	+1.2 yr
PMDA	JP	2034–2038	+1.5 yr
NMPA	CN	2035–2039	+2.3 yr
MFDS	KR	2034–2038	+1.4 yr
CDSCO	IN	2034–2039	+1.8 yr
ANVISA	BR	2035–2039	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	Electret electrostatic physiotherapyFilm
Also known as	polypropylene
Sponsor	Peking University People's Hospital
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Electret electrostatic physiotherapyFilm CI brief — competitive landscape report
Electret electrostatic physiotherapyFilm updates RSS · CI watch RSS
Peking University People's Hospital portfolio CI

Frequently asked questions about Electret electrostatic physiotherapyFilm

What is Electret electrostatic physiotherapyFilm?

Electret electrostatic physiotherapyFilm is a Small molecule drug developed by Peking University People's Hospital.

Who makes Electret electrostatic physiotherapyFilm?

Electret electrostatic physiotherapyFilm is developed by Peking University People's Hospital (see full Peking University People's Hospital pipeline at /company/peking-university-people-s-hospital).

Is Electret electrostatic physiotherapyFilm also known as anything else?

Electret electrostatic physiotherapyFilm is also known as polypropylene.

What development phase is Electret electrostatic physiotherapyFilm in?

Electret electrostatic physiotherapyFilm is in Phase 1.

Manufacturer: Peking University People's Hospital — full pipeline
Also known as: polypropylene

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing